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Climate change induced by recent global warming may 
have  a  significant  impact  on  vector-borne  and  zoonotic 
diseases.  For  example,  the  distribution  of  Japanese 
encephalitis virus (JEV) has expanded into new regions. We 
surveyed  the  levels  of  hemagglutination-inhibition  (HI) 
antibodies  against  JEV  (Family  Flaviviridae,  genus 
Flavivirus) in wild birds captured in Korea. Blood samples 
were collected from 1,316 wild birds including the following 
migratory birds: Oceanodroma castro (n = 4), Anas formosa 
(n = 7), Anas penelope (n = 20), Fulica atra (n = 30), Anas 
acuta (n = 89), Anas crecca (n = 154), Anas platyrhynchos (n 
= 214), Aix galericulata (n = 310), and Anas poecilorhyncha 
(n = 488). All were captured in 16 locations in several Korea 
provinces between April 2007 and December 2009. Out of 
the 1,316 serum samples tested, 1,141 (86.7%) were positive 
for  JEV.  Wild  birds  captured  in  2009  had  a  higher 
seroprevalence of ant-JEV antibodies than those captured 
in 2007. Wild birds with an HI antibody titer of 1 : 1,280 or 
higher  accounted  for  21.2%  (280/1,316)  of  the  animals 
tested. These findings indicated that wild birds from the 
region examined in our study have been exposed to JEV and 
may pose a high risk for introducing a new JEV genotype 
into Korea.
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Introduction
Japanese encephalitis virus (JEV) is a mosquito-borne 
microorganism that causes encephalitis in humans and 
reproductive failure in pregnant sows [1,9]. JEV has been 
recently recognized as a reemerging pathogen as it has 
expanded into new territories such as the Torres Strait and 
Australia [5,10,18-20]. Based on a sequence analysis of the 
C/prM and E genes, JEV has been classified into five 
genotypes; their relationships have been characterized 
[1,7,17]. JEV genotype 1, which was distributed in limited 
regions such as Thailand and Cambodia before the 1990s, 
has expanded into northeastern Asian countries including 
Vietnam, China, Japan, and Korea [7,11,14,19,22]. Although 
the exact mechanisms for the expansion of this genotype 
are unknown, several factors such as bird migration, 
wind-blown mosquitoes, and the transport of animals 
infected with JEV have been suggested [11,13,21]. 
Additionally, climate changes caused by recent global 
warming and extreme weather patterns may have 
significantly impacted the transmission of vector-borne 
diseases such as JEV, West Nile virus (WNV), and 
tick-borne encephalitis virus (TBEV). This is because 
rapid weather and climate changes can directly or 
indirectly affect migratory birds and mosquitoes [12].
Sero-epidemiological studies are critical for predicting 
potentially important viral disease outbreaks and 
preventing the introduction of new JEV genotypes into 
Korea. Recently, Saito et al. [12] suggested that wild ducks 
captured in Hokkaido, Japan can transmit vector-borne 
viruses into new territories. Migratory birds may serve as 
viral reservoirs or amplifying hosts, but they do not 
develop clinical symptoms. Although migrating wild birds 
may be a major JEV vector, no epidemiological survey of 
JEV, which could provide valuable information for 
establishing control measures to prevent JEV outbreaks in 
swine and humans, has been properly conducted for wild 
birds in Korea. Thus, we performed a serological survey to 
determine the prevalence of antibodies against JEV in wild 
birds captured on the Korean peninsula.
Materials and Methods
Collection of serum samples from wild birds
A total of 1,316 blood samples were collected from wild 
birds in 16 locations of six provinces (Gyeonggi-do; 3 site, 
Gyeongsangnam-do; 1 site, Jeollanam-do; 4 sites, 374    Dong-Kun Yang et al.
Table 1. Distribution of hemagglutination inhibition (HI) antibody titers against Japanese encephalitis virus (JEV) according to wild 
bird species
Wild bird
genus and species 
No. of positive (%)
95% CI
HI titer
1 : 20∼≤ 640 (%)
95% CI
≥ 1 : 1,280 (%)
95% CI
Oceanodroma castro 　　　 　　4/4 (100) 　　2 (50.0) 　　2 (50.0)
100 6.8∼93.2 　6.8∼93.2
Anas formosa 　　 　　　7/7 (100) 　　5 (71.4) 　　2 (28.6)
100 29.0∼96.3 　3.7∼71.0
Anas penelope 　　　　16/20 (80.0) 　16 (80.0) 　0 (0.0)
56.3∼94.3 56.3∼94.3 　　 0∼16.8
Fulica atra 　　　　29/30 (96.7) 　20 (66.7) 　　9 (30.0)
82.8∼99.9 47.2∼82.7 14.7∼49.4
Anas acuta 　　 　 89/89 (100) 　65 (73.0) 　24 (27.0)
100 62.6∼81.9 18.1∼37.4
Anas crecca 　　121/154 (78.6) 102 (66.2) 　19 (12.3)
71.2∼84.8 58.2∼73.6 71.2∼84.8
Anas platyrhynchos 　　188/214 (87.9) 132 (61.7) 　56 (26.2)
82.7∼91.9 54.8∼68.2 20.4∼32.6
Aix galericulata 　　244/310 (78.7) 189 (61.0) 　55 (17.7)
73.7∼83.1 55.3∼66.4 13.7∼22.5
Anas poecilorhyncha 　　443/488 (90.8) 330 (67.2) 113 (23.2)
87.9∼93.2 63.3∼71.8 19.5∼27.2
Total 1141/1316 (86.7) 861 (65.4) 280 (21.2)
84.7∼88.5 62.8∼68.0 19.1∼23.6
Jeollabuk-do; 3 sites, Chungcheongnam-do; 3 sites, 
Chungcheongbuk-do; 2 sites) of Korea between April 
2007 and December 2009 for our seroprevalence study. All 
wild birds were lured by rice seed and captured using 
Cannon or Mist net. Blood sample from wing vein of each 
bird using sterile syringe of 3 mL was taken. And then the 
wild birds released after blood sampling. The nine species 
of wild birds tested in this study were Oceanodroma castro 
(four birds), Anas Formosa (seven), Anas Penelope (20), 
Fulica atra (30), Anas acuta (89), Anas crecca (154), Anas 
platyrhynchos (214), Aix galericulata (310), and Anas 
poecilorhyncha (488). Most of the wild birds captured 
were adults. Clotted blood samples were separated by 
3,000× g, and the sera were stored at 򰠏20
oC until use.
Hemagglutination inhibition (HI) test
Before performing the HI test, the sera were inactivated 
by incubating at 56
oC for 30 min. The KV1899 (genotype 
1 strain) strain of JEV was used as the positive antigen for 
the HI test. This strain was isolated from Korean pig blood 
in 1999 and has been passed nine times in Vero cells after 
isolation. To estimate the JEV antibody prevalence in the 
wild bird sera, an HI test was performed in 96-well 
microplates (Corning, USA) using slightly modified 
standard methods [2,8]. A sucrose-acetone extraction 
method was used to prepare viral antigens from the brains 
of suckling mice infected with the Korean isolate of JEV 
strain KV1899. Briefly, 10 μL of the serum samples 
collected from wild birds and 50 μL of 4% bovine albumin 
were mixed with 40 μL of 25% kaolin (Sigma, USA) and 
incubated for 30 min to remove non-specific inhibitors at 
room temperature. After mixing, the kaolin was removed 
by centrifugation at 3,000× g for 15 min. The clear 
supernatant was then mixed with 5 μL of packed goose 
erythrocytes to remove any natural agglutinins. After 
incubating at 37
oC for 1 h, the treated sera were separated 
from the goose erythrocytes by 3,000× g at 4
oC. The sera 
(25 μL) were diluted two-fold from 1 : 20 to 1 : 10,240 in 
round-bottom 96-well microplates (Corning, USA) and 
incubated with 8 hemagglutinating antigen (HA) units of 
JEV. After incubating at 37
oC for 1 h, 50 μL of 0.33% 
goose erythrocytes were added and the microplates were 
incubated for 30 min at 37
oC. To confirm the test reliability, 
porcine control sera positive and negative for JEV were 
used in all HI tests. HI titer was expressed as the reciprocal 
of the highest dilution of serum showing complete 
hemagglutination inhibition. An HI titer of 1 : 20 or higher 
was considered positive.Serosurveillance for JEV in wild birds    375
Table 3. Number of JEV cases from 2007 to 2010 in humans 
residing in Korea
Provinces
No. of JEV cases according to year
Total (%)
2007 2008 2009 2010
GG 5 2 2 10 19 (42.3)
GW 0 0 0 5 5 (11.2)
CB 0 2 1 1 4 (8.8)
CN 0 1 0 3 4 (8.8)
JB 0 0 0 0 0 (0)
JN 0 0 0 1 1 (2.3)
GB 1 1 1 3 6 (13.3)
GN 1 0 2 3 6 (13.3)
Total (%) 7 (15.6)  6 (13.3) 6 (13.3) 26 (57.8) 45 (100)
Data were obtained from Korea Center for Disease Control and 
Prevention (www.cdc.go.kr).




GG GN JN JB CN CB
No. capture sites 3 1 4 3 3 2 16
No. birds sampled 248 80 86 237 457 208 1,316
No. positive ≥ 1 : 20
  (Seropositive rate: %) 210 (84.7) 80 (100) 80 (93.0) 216 (91.1) 379 (82.9) 176 (84.6) 1,141 (86.7)
  95% CI 79.6∼88.9 100 85.4∼97.4 86.8∼94.4 79.2∼86.3 79.0∼89.2 84.7∼88.5
No. positive ≥ 1 : 1,280
  (Seropositive rate: %) 42 (16.9) 21 (26.3) 16 (18.6) 54 (22.8) 102 (22.3) 45 (21.6) 280 (21.2)
  95% CI 12.5∼22.2 17.0∼37.3 11.0∼28.4 17.6∼28.7 18.6∼26.4 16.2∼27.9 19.1∼23.6
*GG: Gyeonggi-do, GN: Gyeongsangnam-do, JN: Jeollanam-do, JB: Jeollabuk-do, CN: Chungcheongnam-do, CB: Chungcheongbuk-do.
Fig. 1. Frequency of the hemagglutination inhibition (HI) titer 
distribution among wild birds which were positive for Japanese 
encephalitis virus (JEV) between 2007 and 2009.
Fig. 2. Average HI titer against JEV according to year.
Statistical analysis
JEV prevalence was estimated as the number of positive 
samples compared to the number of samples tested and 
expressed as a percentage. A 95% confidence interval (CI) 
was calculated for the estimated prevalence. Additionally, 
each titer was classified according to bird species, time 
(year), and place (capture location). The titers were 
estimated and compared using a chi-square test.
Results
JEV seroprevalence as determined by our study is shown 
in Tables 1∼3, and Figs. 1 and 2. The overall prevalence of 
antibodies against JEV was 86.7% (95% CI, 84.7∼88.5%) 
for the 1,316 serum samples consisting of nine wild bird 
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according to year was 68.2% (189 positives/277 tested; 
95% CI, 62.4∼73.7%) for 2007, 86.4% (367/425; 95% CI, 
82.7∼89.5%) for 2008, and 95.3% (585/614; 95% CI, 93.3
∼96.8%) for 2009 (Fig. 2). The regional seroprevalence of 
positive HI titers ≥ 1 : 20 ranged from 82.9 to 100%. 
Compared to other provinces, the Gyeongsangnam-do 
showed the highest prevalence (100%); however, no 
significant difference in regional prevalence was found. 
The regional seroprevalences were 100% (80/80) in 
Gyeongsangnam-do, 93.0% (80/86; 95% CI, 85.4∼97.4%) 
in Jeollanam-do, 91.1% (216/237; 95% CI, 86.8∼94.4%) 
in Jeollabuk-do, 84.7% (210/248; 95% CI, 79.6∼88.9%) 
in Gyeonggi-do, 84.6% (176/208; 95% CI, 79.0∼89.2%) 
in Chungcheongbuk-do, and 82.9% (379/457; 95% CI, 
79.2∼86.3%) in Chungcheongnam-do. The distribution 
of JEV seropositive wild bird species ranged from 78.6 to 
100%. Seroprevalence according to wild bird species were 
100% (4/4; 7/7; 89/89) in Oceanodroma castro,  Anas 
formosa, and Anas acuta (winter visitor); 96.7% (29/30; 
95% CI, 82.8∼99.9%) in Fulica atra, 90.8% (443/488; 
95% CI, 87.9∼93.2%) in Anas poecilorhyncha (migratory 
breeder), 87.9% (188/214; 95% CI, 82.7∼91.9%) in Anas 
platyrhynchos, 80% (16/20; 95% CI, 56.3∼94.3%) in 
Anas penelope (winter visitor), 78.7% in Aix galericulata 
(migratory breeder), and 78.6% (121/154; 95% CI, 71.2∼
84.8%) in Anas crecca. The prevalence of wild birds with 
an HI antibody titer above 1 : 20 or 1 : 1,280 were 86.7% 
and 21.2%, respectively. Wild birds captured in 2009 had a 
higher JEV seropositive rate than those captured in 2007 
(Fig. 2). Among the wild birds captured in 2009 that had an 
HI antibody titer of 1 : 20 or more, the most frequent HI 
titer was 1 : 640 (16.2%).
Discussion
Climate change, global warming, environmental 
destruction, and rapid urbanization can alter wild bird 
migratory paths and increase the incidence of arboviral 
disease outbreaks. Under these conditions, vector-borne 
diseases caused by JEV, WNV, and TBEV may be easily 
introduced into disease-free countries by migratory wild 
birds. Since JEV was first isolated in Korea in 1946 [9], 
several Korean JEV isolates have been reported and 
characterized based on a C/prM and E gene nucleotide 
analysis. Phylogenetic analyses to determine the genetic 
relationships between JEV isolates found that Korean JEV 
isolates changed from genotype 3 to genotype 1 around 
1993 [21]. However, few studies have addressed the 
possibility of JEV introduction into Korea via wild birds. 
Thus, we conducted a nationwide survey of JEV antibodies 
in wild birds, including migratory birds.
In this study, the sera of wild birds that were captured in 
16 locations of the Korean peninsula were tested for the 
presence of JEV antibodies. The overall JEV seropositive 
rate was 86.7%. This HI test result was surprisingly high 
and suggested that most of the wild birds we captured in 
Korea had been exposed to JEV. Saito et al. [12] reported 
that 85.9% and 5.4% of wild ducks captured in Hokkaido, 
Japan have antibodies against JEV according to the 
focus-reduction neutralization test (FRNT50 and FRNT90), 
which is more specific than the HI test. Additionally, 7.2%, 
20.4%, and 28.1% of wild birds in 2007, 2008, and 2009, 
respectively, had a titer > 1 : 1,280. Sugiura and Shimada 
[15] reported that horses experimentally inoculated with 
JEV had an antibody titer of 1 : 1,280 within 2 or 3 weeks 
after inoculation. Therefore, wild birds with titers of 1 : 
1,280 or higher may have been infected with wild JEV 
within 3 weeks. Although we conducted our serosurveillance 
study with an HI test, which is known to be less specific 
than the FRNT, our survey results correspond well with 
those of a previous study in wild ducks in Japan [12]. 
However, cross-reaction between JEV and WNV in 
serodiagnoses is a well-known occurrence in Flavivirus- 
infected animals, including birds [4,6]. Therefore, it is 
necessary to perform a more specific method, such as a 
plaque-reduction neutralization test (PRNT), for JEV 
serosurveillance in birds.
Several positive JEV serosurveillance results have been 
reported in different animals including swine, goats, cattle, 
horses, and wild boars in Japan and Korea [16]. It has been 
suggested that goats may serve as good sentinel animals for 
serological monitoring of JEV infection because they are 
currently not vaccinated against JEV in Korea [21,22]. 
Unlike domestic animals, wild birds cannot be inoculated 
with a JEV vaccine, but they are easily exposed to several 
kinds of arthropods such as mosquitoes, ticks, and midges. 
The high number of positive JEV titers in this study does 
not indicate viral intrusion into Korea since JEV viremia 
ends when JEV-specific antibodies are detected in ducks 
[3]. However, wild birds with viremia may carry JEV to 
several countries.
According to data obtained from the Korean Center for 
Disease Control and Prevention, 45 JEV cases in human 
were reported between 2007 and 2010. More than half of 
these cases occurred in 2010, suggesting that climate 
change or a high JEV infection rate among wild birds may, 
in part, explain the increasing JEV infection rate in the 
human population. Gyeonggi-do had a high incidence rate 
(42.3%) of JEV infection in humans, but no significant 
relationship was found between the seropositive rates in 
the capture areas and the JEV incidence rate in humans. 
Nevertheless, new JEV genotypes may be introduced into 
Korea via wild or migratory birds. It is therefore necessary 
to monitor JEV antibodies using the PRNT in wild birds. 
Taken together, these findings lead us to predict that JEV 
infections may appear in domestic animals such as pigs.
In conclusion, the results of the present study suggested 
that wild birds with a high incidence rate (86.7%) of JEV Serosurveillance for JEV in wild birds    377
antibodies may be introducing new JEV genotypes into 
Korea. Further studies are needed to isolate all JEV 
genotypes from blood obtained from migratory birds. 
Various research projects examining disease distribution 
and transmission associated with climate change in the 
Korean peninsula should also be carried out in the near 
future.
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